Monitoring of in-vivo platelet deposition in patients with peripheral vascular disease after different doses of prostaglandin I2 (PGI2).
D000368:Aged; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D011464:Epoprostenol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007205:Indium Radioisotopes; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D015125:Oxyquinoline / Q000031:analogs & derivatives; D011868:Radioisotopes; D011877:Radionuclide Imaging; D014652:Vascular Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology
D007205:Indium Radioisotopes; D009942:Organometallic Compounds; D011868:Radioisotopes; C032950:indium oxine; D015125:Oxyquinoline; D011464:Epoprostenol